Protein kinase Cα participates in activation of store-operated Ca2+ channels in human glomerular mesangial cells

被引:37
作者
Ma, R [1 ]
Kudlacek, PE [1 ]
Sansom, SC [1 ]
机构
[1] Univ Nebraska, Med Ctr, Dept Physiol & Biophys, Omaha, NE 68198 USA
来源
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY | 2002年 / 283卷 / 05期
关键词
thapsigargin; patch clamp; fura; 2; fluorescence;
D O I
10.1152/ajpcell.00141.2002
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Protein kinase C (PKC) plays an important role in activating store-operated Ca2+ channels (SOC) in human mesangial cells (MC). The present study was performed to determine the specific isoform(s) of conventional PKC involved in activating SOC in MC. Fura 2 fluorescence ratiometry showed that the thapsigargin-induced Ca2+ entry (equivalent to SOC) was significantly inhibited by 1 muM Go-6976 (a specific PKCalpha and betaI inhibitor) and PKCalpha antisense treatment (2.5 nM for 24-48 h). However, LY-379196 (PKCbeta inhibitor) and 2,2', 3,3', 4,4'-hexahydroxy-1,1'-biphenyl-6,6'-dimethanoldimethyl ether (HBDDE; PKCalpha and gamma inhibitor) failed to affect thapsigargin-evoked activation of SOC. Single-channel analysis in the cell-attached configuration revealed that Go-6976 and PKCalpha antisense significantly depressed thapsigargin-induced activation of SOC. However, LY-379196 and HBDDE did not affect the SOC responses. In inside-out patches, application of purified PKCalpha or betaI, but not betaII or gamma, significantly rescued SOC from postexcision rundown. Western blot analysis revealed that thapsigargin evoked a decrease in cytosolic expression with a corresponding increase in membrane expression of PKCalpha and gamma. However, the translocation from cytosol to membranes was not detected for PKCbetaI or betaII. These results suggest that PKCalpha participates in the intracellular signaling pathway for activating SOC upon release of intracellular stores of Ca2+.
引用
收藏
页码:C1390 / C1398
页数:9
相关论文
共 52 条
[1]   PROTEIN-KINASE-C ACTIVATES CAPACITATIVE CALCIUM-ENTRY IN THE INSULIN-SECRETING CELL-LINE RINM5F [J].
BODE, HP ;
GOKE, B .
FEBS LETTERS, 1994, 339 (03) :307-311
[2]   Sequential activation of different Ca2+ entry pathways upon cholinergic stimulation in mouse pancreatic acinar cells [J].
Camello, C ;
Pariente, JA ;
Salido, GM ;
Camello, PJ .
JOURNAL OF PHYSIOLOGY-LONDON, 1999, 516 (02) :399-408
[3]   SEGMENTALLY DISTINCT EFFECTS OF DEPOLARIZATION ON INTRACELLULAR [CA2+] IN RENAL ARTERIOLES [J].
CARMINES, PK ;
FOWLER, BC ;
BELL, PD .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (05) :F677-F685
[4]   Regulation of protein kinase C-δ and -ε isoforms by phorbol ester treatment of LLC-PK1 renal epithelia [J].
Clarke, H ;
Ginanni, N ;
Soler, AP ;
Mullin, JM .
KIDNEY INTERNATIONAL, 2000, 58 (03) :1004-1015
[5]   RETRACTED: Protein kinase C (PKC)-α activation inhibits PKC-ζ and mediates the action of PED/PEA-15 on glucose transport in the L6 skeletal muscle cells (Publication with Expression of Concern. See vol. 67, 2018) (Retracted article. See vol. 68, pg. 464, 2019) [J].
Condorelli, G ;
Vigliotta, G ;
Trencia, A ;
Maitan, MA ;
Caruso, M ;
Miele, C ;
Oriente, F ;
Santopietro, S ;
Formisano, P ;
Beguinot, F .
DIABETES, 2001, 50 (06) :1244-1252
[6]   PROTEIN-KINASE-C - A QUESTION OF SPECIFICITY [J].
DEKKER, LV ;
PARKER, PJ .
TRENDS IN BIOCHEMICAL SCIENCES, 1994, 19 (02) :73-77
[7]   Inhibition of the calcium release-activated calcium (CRAC) current in Jurkat T cells by the HIV-1 envelope protein gp160 [J].
Dellis, O ;
Gangloff, SC ;
Paulais, M ;
Tondelier, D ;
Rona, JP ;
Brouillard, F ;
Bouteau, F ;
Guenounou, M ;
Teulou, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (08) :6044-6050
[8]   The protein kinase Cα binding protein PICK1 interacts with short but not long form alternative splice variants of AMPA receptor subunits [J].
Dev, KK ;
Nishimune, A ;
Henley, JM ;
Nakanishi, S .
NEUROPHARMACOLOGY, 1999, 38 (05) :635-644
[9]   Protein kinase C isoenzymes in rat and human cardiovascular tissues [J].
Erdbrugger, W ;
Keffel, J ;
Knocks, M ;
Otto, T ;
Philipp, T ;
Michel, MC .
BRITISH JOURNAL OF PHARMACOLOGY, 1997, 120 (02) :177-186
[10]  
Gibson A, 1998, TRENDS PHARMACOL SCI, V19, P266